Shanghai Heartcare Medical Technology Corp. Ltd. Class H (HK:6609)
:6609
Want to see HK:6609 full AI Analyst Report?
Total Valuation
Shanghai Heartcare Medical Technology Corp. Ltd. Class H has a market cap or net worth of HK$1.81B. The enterprise value is HK$973.59M.
Market CapHK$1.81B
Enterprise ValueHK$973.59M
Share Statistics
Shanghai Heartcare Medical Technology Corp. Ltd. Class H has 31,565,804 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding31,565,804
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Shanghai Heartcare Medical Technology Corp. Ltd. Class H’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 3.54%.
Return on Equity (ROE)0.07
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)3.54%
Return on Capital Employed (ROCE)0.04
Revenue Per Employee1.19M
Profits Per Employee251.19K
Employee Count344
Asset Turnover0.32
Inventory Turnover0.82
Valuation Ratios
The current PE Ratio of Shanghai Heartcare Medical Technology Corp. Ltd. Class H is 17.8. Shanghai Heartcare Medical Technology Corp. Ltd. Class H’s PEG ratio is -0.03.
PE Ratio17.8
PS Ratio4.47
PB Ratio1.61
Price to Fair Value1.61
Price to FCF13.05
Price to Operating Cash Flow31.09
PEG Ratio-0.03
Income Statement
In the last 12 months, Shanghai Heartcare Medical Technology Corp. Ltd. Class H had revenue of 408.29M and earned 83.33M in profits. Earnings per share was 2.21.
Revenue408.29M
Gross Profit272.17M
Operating Income44.28M
Pretax Income86.41M
Net Income83.33M
EBITDA64.43M
Earnings Per Share (EPS)2.21
Cash Flow
In the last 12 months, operating cash flow was 41.60M and capital expenditures -11.05M, giving a free cash flow of 30.56M billion.
Operating Cash Flow41.60M
Free Cash Flow30.56M
Free Cash Flow per Share0.97
Dividends & Yields
Shanghai Heartcare Medical Technology Corp. Ltd. Class H pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.47
52-Week Price Change65.38%
50-Day Moving Average50.70
200-Day Moving Average52.74
Relative Strength Index (RSI)36.62
Average Volume (3m)127.28K
Important Dates
Shanghai Heartcare Medical Technology Corp. Ltd. Class H upcoming earnings date is Aug 28, 2026, Before Open (Confirmed).
Last Earnings DateMar 26, 2026
Next Earnings DateAug 28, 2026
Ex-Dividend Date―
Financial Position
Shanghai Heartcare Medical Technology Corp. Ltd. Class H as a current ratio of 11.49, with Debt / Equity ratio of 3.77%
Current Ratio11.49
Quick Ratio9.74
Debt to Market Cap0.00
Net Debt to EBITDA-8.49
Interest Coverage Ratio21.48
Taxes
In the past 12 months, Shanghai Heartcare Medical Technology Corp. Ltd. Class H has paid 3.07M in taxes.
Income Tax3.07M
Effective Tax Rate0.04
Enterprise Valuation
Shanghai Heartcare Medical Technology Corp. Ltd. Class H EV to EBITDA ratio is 19.87, with an EV/FCF ratio of 9.14.
EV to Sales3.13
EV to EBITDA19.87
EV to Free Cash Flow9.14
EV to Operating Cash Flow8.30
Balance Sheet
Shanghai Heartcare Medical Technology Corp. Ltd. Class H has HK$718.20M in cash and marketable securities with HK$45.91M in debt, giving a net cash position of HK$672.29M billion.
Cash & Marketable SecuritiesHK$718.20M
Total DebtHK$45.91M
Net CashHK$672.29M
Net Cash Per ShareHK$21.30
Tangible Book Value Per ShareHK$29.54
Margins
Gross margin is 66.66%, with operating margin of 10.85%, and net profit margin of 20.41%.
Gross Margin66.66%
Operating Margin10.85%
Pretax Margin21.16%
Net Profit Margin20.41%
EBITDA Margin15.78%
EBIT Margin10.84%
Analyst Forecast
The average price target for Shanghai Heartcare Medical Technology Corp. Ltd. Class H is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast47.07%
EPS Growth Forecast―